drugset / Trial / NCT00209794

IPTi in Mozambican Infants for Malaria Prevention

NCT00209794

Phase 1/2 Unknown 1498 enrolled Hospital Clinic of Barcelona
RandomizedParallel-groupDouble-blindPrevention

Summary

To evaluate if intermittent preventive treatment in infants (IPTi) consisting of SP \[Fansidar\] given through the EPI scheme alongside routine immunisations at 3, 4 and 9 months of age reduces de incidence of clinical malaria up to 12 months of age

Timeline

Start
2002-09
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject pyrimethamine Small molecule 1.25 mg/kg
Subject sulfadoxine Small molecule 25 mg/kg

Indications